Arcturus Therapeutics Already 4% Down, Almost Two Hours Before The Market Open

(VIANEWS) – The NASDAQ opens in less than two hours and Arcturus Therapeutics‘s pre-market value is already 4.85% down. Arcturus Therapeutics’s last close was $31.53, 16.48% under its 52-week high of $37.75. The last session, NASDAQ ended with Arcturus Therapeutics (ARCT) dropping 4.37% to $31.53. NASDAQ slid 0.56% to $15,011.35, after two sequential sessions in…

Read More

Arcturus Therapeutics Stock Soars 31% In Recent 21 Sessions

(VIANEWS) – Arcturus Therapeutics saw its share price surge 31.7% over 21 sessions from EUR23.94 on November 30th to EUR31.53 on Monday after experiencing a downward trend the previous session. Even as overall NASDAQ decreased 0.56% to EUR15,011.35, Arcturus Therapeutics shares still continued their increase and are currently trading 16.48% below their 52-week high of…

Read More

Arcturus Therapeutics Stock Soars 32% In 21 Sessions: Why The Bullish Trend?

(VIANEWS) – Arcturus Therapeutics stock price increased 32.58% over 21 sessions, from EUR23.91 on November 24th to EUR31.70 as of 03:37 EST Tuesday afternoon after two consecutive days of gains. This surge was in line with overall performance on NASDAQ, which gained 0.19% to EUR14,992.97 despite Arcturus Therapeutics trading 16.03% below its 52-week high of…

Read More

Arcturus Therapeutics Stock Bullish Momentum With A 11.01% Rise On Wednesday

(VIANEWS) – The NASDAQ ended the session with Arcturus Therapeutics jumping 11.01% to $31.83 on Wednesday, following the last session’s downward trend. NASDAQ rose 0.66% to $15,003.22, after five consecutive sessions in a row of gains, on what was a somewhat up trend trading session today. Arcturus Therapeutics’s last close was $28.67, 24.05% under its…

Read More

Ebix And CorEnergy Infrastructure Trust On The List Of Winners And Losers Of Wednesday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are Ebix, Arcturus Therapeutics, and Aspen Group. Rank Financial Asset Price Change Updated (EST) 1 Ebix (EBIX) 1.83 14.06% 2023-12-19 12:26:59 2 Arcturus Therapeutics (ARCT) 31.83…

Read More

Gap And Roadrunner Transportation Systems On The List Of Winners And Losers Of Saturday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are Gap, Tenet Healthcare, and Ross Stores. Rank Financial Asset Price Change Updated (EST) 1 Gap (GPS) 17.92 31.05% 2023-11-17 12:55:16 2 Tenet Healthcare (THC) 64.63…

Read More

Arcturus Therapeutics Stock Was 23.09% Up On Thursday

(VIANEWS) – The NASDAQ ended the session with Arcturus Therapeutics (ARCT) rising 23.09% to $23.88 on Thursday while NASDAQ jumped 0.07% to $14,103.84. Arcturus Therapeutics’s last close was $19.40, 48.61% below its 52-week high of $37.75. About Arcturus Therapeutics Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the…

Read More

Arcturus Therapeutics And Eli Lilly And Company On The List Of Winners And Losers Of Thursday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session. The three biggest winners today are Arcturus Therapeutics, Aspen Group, and Target Corporation. Rank Financial Asset Price Change Updated (EST) 1 Arcturus Therapeutics (ARCT) 23.88 23.09% 2023-11-15 12:15:37 2 Aspen Group…

Read More

Arcturus Therapeutics Soars 23%: Investors Bet On Success

(VIANEWS) – Arcturus Therapeutics’ (NASDAQ: ARCT) shares surged 23.09% to EUR23.88 at 21:33 EST on Wednesday, following their upward trajectory since Tuesday’s session and as the stock market as a whole showed positivity – rising 0.24% overall and reaching EUR14,128.19! Arcturus Therapeutics closed at EUR19.40 on November 25, 48.61% below its 52-week high of EUR37.75….

Read More